A rare case of amelanotic malignant melanoma in the oral region: Clinical investigation and immunohistochemical study

Ohnishi,Yuichi; Watanabe,Masahiro; Fujii,Tomoko; Sunada,Noriko; Yoshimoto,Hitoshi; Kubo,Hirohito; Wato,Masahiro; Kakudo,Kenji

doi:10.3892/ol.2015.3819

A rare case of amelanotic malignant melanoma in the oral region: Clinical investigation and immunohistochemical study

Authors:
- Yuichi Ohnishi
- Masahiro Watanabe
- Tomoko Fujii
- Noriko Sunada
- Hitoshi Yoshimoto
- Hirohito Kubo
- Masahiro Wato
- Kenji Kakudo
View Affiliations

Affiliations: Second Department of Oral and Maxillofacial Surgery, Osaka Dental University, Chuo‑ku, Osaka 540‑0008, Japan, Department of Oral Pathology, Osaka Dental University, Hirakata‑shi, Osaka 573‑1121, Japan
Published online on: October 20, 2015 https://doi.org/10.3892/ol.2015.3819
Pages: 3761-3764

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Amelanotic malignant melanoma (AMM) is rare in the oral region. The present study examined the clinical features of this tumor in an attempt to establish diagnostic criteria. The expression of three melanocytic differentiation markers, HMB‑45, S‑100 and Melan‑A, was also measured in primary oral AMMs in order to determine whether the markers could be used to diagnose primary oral AMMs and to find out which marker was the most sensitive. It may be particularly difficult to correctly diagnose AMM that lacks a radial growth phase without immunohistochemical assistance. In the present study, mixtures of polygonal and spindle cells at different ratios were observed in the tumors with and without a radial growth phase. Immunohistochemistry was used to examine the HMB‑45, S‑100 and Melan‑A expression in the formalin‑fixed paraffin‑embedded specimens of primary oral AMMs. Comparison of staining intensities (SIs) and labeling indices (LIs) of the markers was also performed. The immunostaining results revealed that the SI of Melan‑A was significantly higher than that of S‑100 (P=0.0011). HMB‑45, S‑100 and Melan‑A also exhibited high positive rates and LIs in AMMs and, therefore, may be good markers for the immunohistochemical diagnosis of primary oral AMMs. Furthermore, Melan‑A may be a more sensitive marker than S‑100 and HMB-45, as it has a higher SI.

View Figures

View References

1	Manganaro AM, Hammond HL, Dalton MJ and Williams TP: Oral melanoma: Case reports and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 80:670–676. 1995. View Article : Google Scholar : PubMed/NCBI
2	Rapini RP: Oral melanoma: Diagnosis and treatment. Semin Cutan Med Surg. 16:320–322. 1997. View Article : Google Scholar : PubMed/NCBI
3	Gazit D and Daniels TE: Oral melanocytic lesions: Differences in expression of HMB-45 and S-100 antigens in round and spindle cells of malignant and benign lesions. J Oral Pathol Med. 23:60–64. 1994. View Article : Google Scholar : PubMed/NCBI
4	Hirano T: Immunohistochemical study of malignant melanoma. Acta Pathol Jpn. 36:733–743. 1986.PubMed/NCBI
5	Tanaka N, Amagasa T, Iwaki H, Shioda S, Takeda M, Ohashi K and Reck SF: Oral malignant melanoma in Japan. Oral Surg Oral Med Oral Pathol. 78:81–90. 1994. View Article : Google Scholar : PubMed/NCBI
6	Tanaka N, Mimura M, Ichinose S and Odajima T: Malignant melanoma in the oral region: Ultrastructural and immunohistochemical studies. Med Electron Microsc. 34:198–205. 2001. View Article : Google Scholar : PubMed/NCBI
7	Prasad ML, Jungbluth AA, Iversen K, Huvos AG and Busam KJ: Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Am J Surg Pathol. 25:782–787. 2001. View Article : Google Scholar : PubMed/NCBI
8	Kilpatrick SE, White WL and Browne JD: Desmoplastic malignant melanoma of the oral mucosa. An underrecognized diagnostic pitfall. Cancer. 78:383–389. 1996. View Article : Google Scholar : PubMed/NCBI
9	Blessing K, Sanders DS and Grant JJ: Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology. 32:139–146. 1998. View Article : Google Scholar : PubMed/NCBI
10	Jungbluth AA, Busam KJ, Gerald WL, Stockert E, Coplan KA, Iversen K, MacGregor DP, Old LJ and Chen YT: A103: An anti-Melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol. 22:595–602. 1998. View Article : Google Scholar : PubMed/NCBI
11	Barrett AW, Bennett JH and Speight PM: A clinicopathological and immunohistochemical analysis of primary oral mucosal melanoma. Eur J Cancer B Oral Oncol. 31B:100–105. 1995. View Article : Google Scholar : PubMed/NCBI
12	Moore BW: A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun. 19:739–744. 1965. View Article : Google Scholar : PubMed/NCBI
13	Nakajima T, Watanabe S, Sato Y, Kameya T, Shimosato Y and Ishihara K: Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus and its diagnostic application. Cancer. 50:912–918. 1982. View Article : Google Scholar : PubMed/NCBI
14	Nobuyuki T, Teruo A, Hiroshi I, Shigetoshi S, Masamune T, Kenichi O and Steven F: Oral malignant melanoma in Japan. Oral Surg Oral Med Oral Pathol. 78:81–90. 1994. View Article : Google Scholar : PubMed/NCBI
15	Gown AM, Vogel AM, Hoak D, Gough F and McNutt MA: Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol. 123:195–203. 1986.PubMed/NCBI
16	Rapini RP, Golitz LE, Greer RO Jr, Krekorian EA and Poulson T: Primary malignant melanoma of the oral, cavity. A review of 177 cases. Cancer. 55:1543–1551. 1985. View Article : Google Scholar : PubMed/NCBI
17	Sensi M, Traversari C, Radrizzani M, Salvi S, Maccalli C, Mortarini R, Rivoltini L, Farina C, Nicolini G, Wolfel T, et al: Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1. Proc Natl Acad Sci USA. 92:5674–5678. 1995. View Article : Google Scholar : PubMed/NCBI
18	Salvi S, Segalla F, Rao S, Arienti F, Sartori M, Bratina G, Caronni E, Anichini A, Clemente C, Parmiani G, et al: Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas. Cancer Res. 55:3374–3379. 1995.PubMed/NCBI
19	Ishida H, Nagai T, Sato S, Honda M, Uotani T, Samejima K, Hanaoka T, Akahori T, Takai Y and Seki H: Concomitant sentinel lymph node biopsy leading to abbreviated systematic lymphadenectomy in a patient with primary malignant melanoma of the vagina. Springerplus. 4:1022015. View Article : Google Scholar : PubMed/NCBI
20	Tanaka N, Mimura M, Kimijima Y and Amagasa T: Clinical investigation of amelanotic malignant melanoma in the oral region. J Oral Maxillofac Surg. 62:933–937. 2004. View Article : Google Scholar : PubMed/NCBI
21	Ariel IM: Amelanotic melanomas: An analysis of 77 patients. Curr Surg. 38:151–155. 1981.PubMed/NCBI
22	Fujita S, Takahashi H, Tsuda N and Okabe H: Immunohistochemical localization of S-100 protein and its subunits in melanotic lesion in the oral mucosa and skin. J Oral Pathol Med. 20:429–432. 1991. View Article : Google Scholar : PubMed/NCBI
23	Naoki O Kawada: The stage of melanogenesis in amelanotic melanoma. Melanoma in the Clinic - Diagnosis, Management and Complications of Malignancy. Murph M: (InTech). 277–283. 2011.
24	Naoki O, Masuki Y, Shigeru K and Akira K: Amelanotic vulvar melanoma with intratumor histological heterogeneity. J Dermatol. 37:537–5412010.